Blaise_logo_splashBlaise_logo_splashBlaise_logo_splashBlaise_logo_splash
  • Home
  • About
    • Overview
    • Market Expertise
      • Biotechnology
      • Pharmaceuticals
      • Medical Devices
      • Contract Services
    • Letter From the Chairman
  • Search Services
    • Search Services
    • CEO
    • Board
    • Executive
    • Sample Placements
  • Search Process
    • Search Process
    • Step-By-Step
    • Diversity Initiatives
    • Succession Planning
  • Strategic Services
  • Client Login
  • Candidate Login
  • News & Events
    • News
    • Events
  • Contact
✕
All Aboard! Takeda’s Dengue Fever Vaccine Holds Up Over 4.5 Years
June 9, 2022
Actor Greg Grunberg Discusses New Series: “The Care Giver”
June 9, 2022
All Aboard! Takeda’s Dengue Fever Vaccine Holds Up Over 4.5 Years
June 9, 2022
Actor Greg Grunberg Discusses New Series: “The Care Giver”
June 9, 2022
0
Published by at June 9, 2022
Categories
Tags

Bluebird gene therapy overcomes safety worries to snag a win at FDA advisory panel
esagonowsky
Thu, 06/09/2022 – 16:07

CALIFORNIA

Blaise Group International 
Corporate Headquarters

101 Pacifica, Suite 280
Irvine, CA 92618
Telephone: +1 (949) 502-4070
Fax: +1 (949) 502-4069
[email protected]

NEW YORK

Blaise Group International
New York
New York Rockefeller Center
1 Rockefeller Plz, FL 11
New York, NY 10020
Telephone: +1 (917) 588-3700
Fax: +1 (212) 618-6309
[email protected]

LONDON

 Blaise Group International
London

Berkeley Square House
Berkeley Square 2nd Floor
London W1J6BD United Kingdom
Telephone: +44 20 7887 6197
Fax: +44 20 7887 6001
[email protected]

Contact Us

  • This field is for validation purposes and should be left unchanged.

© 2017 Blaise Group International All rights reserved. Orange County Web Design by LightHouse Graphics